RH·4

Apr 1, 8:00 PM ET

Chaya Eri 4

4 · RH · Filed Apr 1, 2026

Research Summary

AI-generated summary of this filing

Updated

RH Director Chaya Eri Exercises Options, Sells Shares

What Happened Chaya Eri — RH’s President, Co‑Chief Creative & Merchandising Officer and Director — exercised 11,000 stock options (exercise price $39.42) on March 31, 2026, paying $433,620. On the same day she sold 11,000 shares in multiple open‑market transactions for a total of approximately $1,517,145. The filings also show a $0 disposition of 11,000 derivative shares (reported separately), which is commonly used for net settlement/withholding.

Key Details

  • Transaction date: 2026-03-31; Form 4 filed 2026-04-01 (timely).
  • Option exercise: 11,000 shares at $39.42 each — cash paid $433,620 (footnote F9: option fully vested).
  • Open‑market sales: 11,000 shares sold across multiple trades; total proceeds ≈ $1,517,145 (weighted average blocks reported between ~$134.58 and $140.64; see F2–F7).
  • Net proceeds (sales minus exercise cost): ≈ $1,083,525 (before taxes/fees).
  • Plan/footnotes: Sales effected under a Rule 10b5‑1 trading plan adopted Oct 7, 2024 (F1). Some shares/holdings referenced as held by the Chaya‑Smith Revocable Trust (F8).
  • Shares owned after the transactions: not specified in the provided summary — see the SEC filing for exact post‑transaction beneficial ownership.
  • Filing appears timely (no late filing flag).

Context This transaction combines an option exercise (derivative transaction, code M) and immediate open‑market sales. Exercising options and selling resulting shares is common for liquidity or tax purposes; the presence of a pre‑arranged 10b5‑1 plan indicates sales were executed under an established trading plan rather than ad‑hoc trades. For full details (per‑trade prices, exact post‑transaction holdings), refer to the submitted Form 4 (Accession No. 0001560810-26-000006).

Insider Transaction Report

Form 4
Period: 2026-03-31
RHRH
Chaya Eri
DirectorSEE REMARKS
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-31$39.42/sh+11,000$433,62011,000 total
  • Sale

    Common Stock

    [F1][F2]
    2026-03-31$135.27/sh1,100$148,8009,900 total
  • Sale

    Common Stock

    [F1][F3]
    2026-03-31$135.93/sh2,000$271,8627,900 total
  • Sale

    Common Stock

    [F1][F4]
    2026-03-31$137.04/sh1,600$219,2706,300 total
  • Sale

    Common Stock

    [F1][F5]
    2026-03-31$138.21/sh1,678$231,9204,622 total
  • Sale

    Common Stock

    [F1][F6]
    2026-03-31$139.38/sh2,922$407,2581,700 total
  • Sale

    Common Stock

    [F1][F7]
    2026-03-31$140.02/sh1,700$238,0350 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F9]
    2026-03-3111,00025,000 total
    Exercise: $39.42Exp: 2026-05-03Common Stock (11,000 underlying)
Holdings
  • Common Stock

    [F8]
    (indirect: By Trust)
    23,643
Footnotes (9)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024.
  • [F2]This transaction was executed in multiple trades ranging from $134.58 to $135.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]This transaction was executed in multiple trades ranging from $135.58 to $136.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F4]This transaction was executed in multiple trades ranging from $136.65 to $137.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F5]This transaction was executed in multiple trades ranging from $137.72 to $138.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F6]This transaction was executed in multiple trades ranging from $138.75 to $139.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F7]This transaction was executed in multiple trades ranging from $139.75 to $140.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F8]Held by the Chaya-Smith Revocable Trust.
  • [F9]This option award is fully vested and exercisable.
Signature
/s/ Jill Falor, Attorney-in-Fact|2026-04-01

Documents

1 file
  • 4
    form4-04012026_080401.xmlPrimary